:: Volume 20, Issue 5 (Bimonthly 2016) ::
Feyz 2016, 20(5): 441-446 Back to browse issues page
Association of miR-143 rs41291957 and rs4705342 genetic variants with endometriosis risk in infertile women
Elaheh Nimi-Hoveidi, Leila Kohan *, Seyyedeh Sara Hashemi
Department of Biology, Arsanjan Branch, Islamic Azad University, Arsanjan, I. R. Iran. , kohan@iaua.ac.ir
Abstract:   (2438 Views)

Background: Infertility is one of the major human problems. One of the most important causes of infertility is endometriosis. Endometriosis, defined as the growth of endometrial tissue outside the uterine cavity, is a common gynecological disorder. Recent research has shown that miRNAs and their target mRNAs are differentially expressed in endometriosis. The aim of this study was to investigate the association of miR-143 rs41291957 and rs4705342 gene variants with endometriosis in infertile women.

Materials and Methods: This case-control study was done on Iranian women (n=303) from March to February 2014. Blood samples from infertile women (n=77) with endometriosis and age-matched healthy women (n=226) at the Zeinabieh Hospital (Shiraz, Iran) were collected. The MiR-143 rs4705342 and rs41291657 genotypes were determined using Tetra-ARMS PCR and PCR-RFLP methods, respectively.

Results: There was a significant difference in the genotype distribution and allele frequency of rs4705342 polymorphism between case and control groups; TC genotype (OR: 2.3, 95%CI: 1-5.3, P=0.04) and C allele were associated with an increased risk of endometriosis (OR: 2.24, 95% CI: 1-4.9, P=0.04). Also, an allele of rs41291957 polymorphism showed a significant association with susceptibility to endometriosis (OR: 2, 95% CI: 1-4, P=0.04).

Conclusion: The finding of this study indicated that for the first time, there was a significant association between miR-143 polymorphisms and the risk of endometriosis. Further studies in other populations with larger samples are needed to confirm these findings.

Keywords: Infertility, Endometriosis, MiR-143, Polymorphism, miRNA
Full-Text [PDF 308 kb]   (742 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2016/11/13 | Accepted: 2016/11/13 | Published: 2016/11/13
References
1. Motovali-Bashi M, Hojati Z, Rezaei Z, Hemmati S. Investigation of association between genetic diversities in Yq11.223 region with men infertility in Isfahan population. J Isfahan Med Sch 2011; 142(2): 707-14. [in Persian]
2. Motovali-bashi M, Miroliaei M, Sedaghat S, Ahmadi SM. Effect of PON1 L55M polymorphism on infertility among Iranian females population. Iran J Biol 2012; 2(25): 230-9. [in Persian]
3. Ozkan S, Murk W, Arici A. Endometriosis and Infertility: Epidemiology and Evidence-based T reatments. Ann N Y Acad Sci 2008; 1127(1): 92–100.
4. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet 2010; 27)8(: 441–7.
5. Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272(2): 95–108.
6. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13(11):797–806.
7. Pan Q, Luo X, Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med 2008; 12(1): 227–40.
8. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285(2):116-26.
9. Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. Lancet Oncol 2011; 12(4): 319-21.
10. Santamaria X, Taylor H. MicroRNA and gynecological reproductive diseases. Fertil Steril 2014; 101(6): 1545–51.
11. Zheng B, Xue X, Zhao Y, Chen J, Xu Ch-Y and Duan P. The differential expression of microRNA-143/145 in endometriosis. Iran J Reprod Med 2014; 12(8): 555-60.
12. Kohan L, Zarei A, Fallahi S, Tabiee O. Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk. Gene 2014; 539(2): 209-12.
13. Bulun SE. Mechanisms of disease endometriosis. N Engl J Med 2009; 360(3): 268-79.
14. Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril 2006; 86:1561–72.
15. Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagné D, Hugo P, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril 2004; 81(6): 1513–21.
16. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril 2013; 99(4): 1135–45.
17. Low WY, Edelmann RJ, Sutton C. A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins. J Psychosom Res 1993; 37(2): 111-6.
18. ZhaoW, Zhao SP, Zhao YH. MicroRNA-143/-145 in Cardiovascular Diseases. Biomed Res Int 2015; 2015: 531740.
19. Fu X, Guo L, Jiang ZM, Zhao LS, Xu AG. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med 2014; 7(7):1813-7.
20. Chu H, Zhong D, Tang J, Li J, Xue Y, Tong N, et al. A functional variant in miR‑143 promoter contributes to prostate cancer risk. Arch Toxicol 2016; 90(2): 403-14.
21. Yang L, Gao X, Luo H, Huang Q, Wei Y, Zhang G, et al. No Association of Pri-miR-143 rs41291957 Polymorphism with the Risk of Congenital Heart Disease in a Chinese Population. Pediatr Cardiol 2014; 35(6): 1057-61.
22. Li L, Pan X, Li Z, Bai P, Jin H, Wang T, et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol 2013; 74(8): 993-7.


XML   Persian Abstract   Print



Volume 20, Issue 5 (Bimonthly 2016) Back to browse issues page